Left ventricular assist device-associated endocarditis involving multiple clones of Staphylococcus aureus with distinct antimicrobial susceptibility patterns

Int J Infect Dis. 2019 Jul:84:44-47. doi: 10.1016/j.ijid.2019.05.001. Epub 2019 May 7.

Abstract

The case of a patient with left ventricular assist device (LVAD)-associated endocarditis involving multiple clones of Staphylococcus aureus is presented. Different clones with distinct colony morphology were identified from blood cultures collected on the same day and showed diverse antimicrobial resistance patterns. In addition, a difference in antimicrobial susceptibility was observed even within an identical clone recovered 400 days apart due to the loss of SCCmec for methicillin and modification of the 23S rRNA target site for linezolid during a long-term treatment course.

Keywords: Endocarditis; Left ventricular assist device; Linezolid resistance; Staphylococcus aureus; Whole-genome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / etiology*
  • Endocarditis, Bacterial / microbiology
  • Heart Ventricles*
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Linezolid / therapeutic use
  • Male
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Microbial Sensitivity Tests
  • Middle Aged
  • RNA, Ribosomal, 23S
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus* / drug effects
  • Staphylococcus aureus* / genetics

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 23S
  • Linezolid